Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA expands approval of breast cancer drug Kisqali
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients: Weighing The Risks & Benefits of Kisqali
The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) as treatment for people with HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence.
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of the breakthrough drug
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-posit
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery.
Targeted Oncology
2d
Ribociclib-Based Therapy Extends Survival in HR+/HER2– Breast Cancer
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
pharmaphorum
3d
Lilly on alert as new Kisqali approval threatens Verzenio
Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Boeing defense chief exits
Sesame Place suit verdict
Drug price challenge revived
Secret Service probing post
SC 1st execution in 13 years
Body found in SUV
Russia threatens retaliation
Feds subpoena Schaeffer
$230 million crypto theft
Pandas leaving for China
Whooping cough cases spike
Jurors begin deliberations
FDA approves flu vaccine
House repeals emission rules
WI high court to decide
Hand count approved in GA
144K+ Mavericks recalled
Sues pharmacy middlemen
Bill to boost security OK'd
Top Hezbollah leader killed?
Hiker injured in bear attack
1st rabies outbreak in seals
In-person voting begins
Baby powder recalled
Stein's ballot bid rejected
Raises settlement offer
Recalling 449K+ vehicles
MS sheriff's office probe
Disney to stop using Slack
Related topics
Food and Drug Administration
Breast cancer
Feedback